H. Lundbeck A/S Newsletter
-
Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer
16 Apr 2024 17:00 GMT
… Lilly and Company, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer … and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer … and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer …
-
Lundbeck and Vernalis present new LRRK2 and LRRK2 G2019S mutant inhibitors
11 Apr 2024 17:17 GMT
-
H. Lundbeck gets grant for modulators of ABHD12 for treating cancer and infectious diseases
10 Apr 2024 13:30 GMT
… ’s company profile on H. Lundbeck, was a key innovation area … identified from patents. H. Lundbeck's grant share as … ’s detailed insights on H. Lundbeck, buy the report here.
From …
-
Lundbeck to Present Data on Migraine Impact Reduction and Sustained Response with VYEPTI® (eptinezumab-jjmr) at 76th Annual Meeting of the American Academy of Neurology
09 Apr 2024 12:34 GMT
… physician and patient perspectives.
About Lundbeck
Lundbeck US refers to the wholly … , HLUNA DC / HLUNB DC) (“Lundbeck”), a global pharmaceutical company specialized … in brain diseases, including Lundbeck LLC and Lundbeck Pharmaceuticals LLC. For more …
-
Otsuka and Lundbeck’s schizophrenia treatment gains EC approval
28 Mar 2024 11:20 GMT
… Otsuka Pharmaceutical Europe and H Lundbeck’s Abilify Maintena 720mg… whom were diagnosed with schizophrenia.
Lundbeck research and development executive vice …
-
Lundbeck initiates Lu AG09222 migraine prevention trial
18 Mar 2024 14:22 GMT
Biopharmaceutical company H. Lundbeck has initiated the PROCEED Phase … the below form
By GlobalData
Lundbeck research and development head, and … our neurology pipeline and emphasises Lundbeck’s commitment to people living …
-
Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer’s Disease
18 Mar 2024 12:11 GMT
… , executive vice president, Lundbeck Research & Development. … en/.
About Lundbeck
Lundbeck US refers to the … diseases, including Lundbeck LLC and Lundbeck Pharmaceuticals LLC. … subsidiaries, including Lundbeck LLC and Lundbeck Pharmaceuticals LLC, …
-
Lundbeck announces executive management changes
27 Feb 2024 13:12 GMT
… President and CEO of Lundbeck.
Advertisement
Michala Fischer-Hansen … Michala Fischer-Hansen to Lundbeck. Michala brings a … Business Development, reporting to Lundbeck’s President and CEO, … and Corporate Strategy
Finally, Lundbeck has initiated a comprehensive …
-
Lundbeck CEO eyes deals to bolster pipeline, complement growth drivers ahead of patent losses
23 Jan 2024 16:04 GMT
… Trintellix/Brintellix as Lundbeck’s top brand by sales … exclusivity in 2029, allowing Lundbeck a longer runway to grow … the brand.
Currently, Lundbeck is “investing significantly” to … patent cliffs are pushing Lundbeck toward building a pipeline that …
-
Lundbeck encourages migraine patients to ‘Say Yep’ to its IV-infused med in latest campaign
19 Jan 2024 20:10 GMT
Lundbeck is taking a new tack …